XLO · Xilio Therapeutics, Inc.
$9.13
-0.02 (-0.22%)
At close · Jul 29
Market Cap
$52.91M
Shares
5.78M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-12 | 2026-06-10 | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| DEF 14A | 2026-04-28 | 2026-06-10 | |
| 8-K | 2026-04-16 | 2026-04-15 | |
| 8-K | 2026-03-23 | — | |
| 10-K | 2026-03-23 | 2025-12-31 | |
| 8-K | 2026-03-12 | — | |
| 8-K | 2026-03-09 | — | |
| 8-K | 2026-02-24 | 2026-02-23 | |
| 8-K | 2026-02-12 | 2026-02-11 | |
| DEF 14A | 2026-01-26 | 2026-02-23 | |
| 8-K | 2026-01-08 | 2026-01-06 | |
| 8-K | 2026-01-05 | — | |
| 8-K | 2025-11-25 | 2025-11-21 | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-13 | — | |
| 8-K | 2025-11-07 | — | |
| DEF 14A | 2025-10-20 | 2025-11-21 | |
| 8-K | 2025-10-03 | 2025-10-02 | |
| 8-K | 2025-09-09 | — | |
| 8-K | 2025-08-28 | 2025-08-22 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-14 | — | |
| 8-K | 2025-06-12 | 2025-06-10 | |
| 8-K | 2025-06-10 | — | |
| 8-K | 2025-06-03 | 2025-06-02 | |
| 8-K | 2025-06-02 | 2025-05-31 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-28 | 2025-06-10 | |
| 8-K | 2025-04-08 | 2025-04-04 | |
| 8-K | 2025-03-11 | — | |
| 8-K | 2025-03-11 | — | |
| 10-K | 2025-03-11 | 2024-12-31 | |
| 8-K | 2025-02-12 | 2025-02-10 | |
| 8-K | 2025-01-21 | — | |
| 8-K | 2024-12-19 | 2024-12-18 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-09-13 | 2024-09-10 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-06-17 | 2024-06-13 | |
| 8-K | 2024-06-13 | — | |
| 8-K | 2024-05-14 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| DEF 14A | 2024-04-25 | 2024-06-13 | |
| 10-K | 2024-04-01 | 2023-12-31 | |
| 8-K | 2024-04-01 | — |
Showing 1–50 of 93 filings